UMC Health System is the first in West Texas to offer the ReShape® Integrated Dual Balloon, an FDA approved, first-of-its-kind, non-surgical weight loss procedure for people with mild to moderate obesity. Little progress has been made in the last 20 years to find non-invasive treatment options that can effectively complement sensible eating habits and physical activity to achieve desired and sustainable weight loss. ReShape provides a new option for adults with a BMI of 30-40 and a related health condition who haven’t succeeded at diet and exercise alone and do not want or do not qualify for bariatric surgery.
ReShape is a next generation technology with features that are designed to enhance performance in three important areas:
- Two connected balloons have a larger fill volume than a typical single balloon.
- It is designed for greater comfort by mounting the two balloons on a flexible shaft that allows the device to conform to the natural shape of the stomach.
- It is the only intragastric balloon that incorporates a feature that is designed to mitigate the potential for migration of a deflated balloon from the stomach into the intestines.
The ReShape Dual Balloon is placed in the stomach during an outpatient procedure that typically takes 20 minutes using conscious sedation (light anesthesia). An endoscope is inserted through the mouth into the stomach and the un-inflated dual balloon is advanced over a guide wire, and precisely placed in the stomach where it is inflated with saline. The dual balloon occupies existing space in the stomach for six months, serving as built-in portion control so patients may feel full and satisfied with less food. It does not change or alter the natural anatomy of the stomach in any way.
During this time and for the six months after removal, patients receive frequent in-office diet and exercise coaching sessions and access to the ReShape Patient Portal, an online support resource that provides tools and information to help patients track weight loss, diet, and exercise, and an on-line community where they can interact with each other.
In an FDA clinical study, patients with ReShape experienced 2.3 times more excess weight loss at six months compared to those who had the diet and exercise program alone. In the clinical trial, patients lost up to 72 pounds in 12 months.
Today, more than 60 million Americans are believed to be within the BMI range of 30-40, many of whom have struggled with a lack of effective weight loss options. Fortunately, the tide is turning in obesity treatment, and ReShape provides a truly unique, next generation treatment option that can deliver sustained results and significant life changes for patients.